Prevalence and Typing of HPV DNA in Atypical Squamous Cells in Pregnant Women

Acta Cytologica

Volumn 47, Issue 6, 2003, Pages 1008-1016

  Lu, Danielle W ^a,b   Pirog, Edyta C ^c   Zhu, Xiaopei ^a   Wang, Hanlin L ^a   Pinto, Karen R ^a,d  

^a WASHINGTON UNIVERSITY   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atypical squamous cells; Cervix neoplasms; Mass screening; Papillomavirus, human; Pregnancy

Indexed keywords

VIRUS DNA;

ARTICLE; ATYPICAL SQUAMOUS CELL; CONTROLLED STUDY; CYTOPATHOLOGY; DNA DETERMINATION; DNA FINGERPRINTING; EPITHELIUM CELL; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PAPANICOLAOU TEST; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; UTERINE CERVIX DISEASE; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0344033739     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326637     Document Type: Article

References (36)

1. Solomon D, Frable WJ, Vooijs GP, Wilbur DC, Amma NS, Collins RJ, Davey DD, Knight BK, Luff RD, Meisels A, Navin J, Rosenthal DL, Sauer T, Stoler M, Suprun HZ, Yamauchi K: ASCUS and AGUS criteria: International Academy of Cytology Task Force summary: Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol 1998;42:16-24
2. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ: Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-954
3. Wright TC, Sun XW, Koulos J: Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-210
4. Kinney WK, Manos MM, Hurley LB, Ransley JE: Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-976
5. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119
6. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129
7. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
8. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ: Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-337
9. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA: Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610
10. Sherman ME, Schiffman MH, Lorincz AT, Herrero R, Hutchinson ML, Bratti C, Zahniser D, Morales J, Hildesheim A, Helgesen K, Kelly D, Alfaro M, Mena F, Balmaceda I, Mango L, Greenberg M: Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer 1997;81:89-97
11. Kim JJ, Wright TC, Goldie SJ: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390
12. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287:2372-2381
13. Pisharodi LR, Jovanoska S: Spectrum of cytologic changes in pregnancy: A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol 1995;39:905-908
14. Michael CW, Esfahani FM: Pregnancy-related changes: A retrospective review of 278 cervical smears. Diagn Cytopathol 1997;17:99-107
15. Kiguchi K, Bibbo M, Hasegawa T, Kurihara S, Tsutsui F, Wied GL: Dysplasia during pregnancy: A cytologic follow-up study. J Reprod Med 1981;26:66-72
16. Kaminski PF, Lyon DS, Sorosky JI, Wheelock JB, Podczaski ES: Significance of atypical cervical cytology in pregnancy. Am J Perinatol 1992;9:340-343
17. Schneider A, Hotz M, Gissmann L: Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987;40:198-201
18. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R: Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996;174:1487-1493
19. Fife KH, Katz BP, Brizendine EJ, Brown DR: Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol 1999;180:1110-1114
20. Rando RF, Lindheim S, Hasty L, Sedlacek TV, Woodland M, Eder C: Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989;161:50-55
21. Lundvall L: Comparison between abnormal cytology, colposcopy and histopathology during pregnancy. Acta Obstet Gynecol Scand 1989;68:447-452
22. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B, Quint W: Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-1739
23. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-2517
24. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354
25. Pinto KR, Pinto A, Lu D: Follow-up study of atypical squamous cells of undetermined significance (ASCUS) in pregnancy (abstr). Proc of 49th Annual Scientific Meeting of the American Society of Cytopathology, Kansas City, Missouri, 2001
26. Wright TC Jr, Lorincz A, Ferris DG, Richart RM, Ferenczy A, Mielzynska I, Borgatta L: Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998;178:962-966
27. Sherman ME, Schiffman M, Cox JT: Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-107
28. Crum CP: Detecting every genital papilloma virus infection: What does it mean? Am J Pathol 1998;153:1667-1671
29. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G: Human papillomavirus infection is transient in young women: A population-based cohort study. J Infect Dis 1995;171:1026-1030
30. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM: Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53:919-923
31. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428
32. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-1278
33. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ: PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996;68:766-769
34. Keating JT, Wang HH: Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer 2001;93:100-105
35. Bolick RB, Staley BE, Schwarz CM, Lin KK: The rate of oncogenic HPV decreases with age in all Pap diagnostic groups (abstr). Proc of 49th Annual Scientific Meeting of the American Society of Cytopathology, Salt Lake City, Utah, 2002
36. DeMay RM: The Art and Science of Cytopathology. First volume: Exfoliative Cytology. Chicago, ASC Press, 1996, pp 116-118